HK1081225A1 - Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same - Google Patents
Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using sameInfo
- Publication number
- HK1081225A1 HK1081225A1 HK06100997.7A HK06100997A HK1081225A1 HK 1081225 A1 HK1081225 A1 HK 1081225A1 HK 06100997 A HK06100997 A HK 06100997A HK 1081225 A1 HK1081225 A1 HK 1081225A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- making
- materials
- methods
- same
- derived therefrom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/04—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from germ cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25394300P | 2000-11-30 | 2000-11-30 | |
PCT/US2001/044627 WO2002102997A2 (en) | 2000-11-30 | 2001-11-30 | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1081225A1 true HK1081225A1 (en) | 2006-05-12 |
Family
ID=22962299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06100997.7A HK1081225A1 (en) | 2000-11-30 | 2006-01-23 | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
Country Status (12)
Country | Link |
---|---|
US (1) | US20020168763A1 (ru) |
EP (1) | EP1395652A2 (ru) |
JP (2) | JP2004532648A (ru) |
KR (2) | KR20030088022A (ru) |
CN (1) | CN100422315C (ru) |
AU (1) | AU2001297880B2 (ru) |
CA (1) | CA2430627A1 (ru) |
HK (1) | HK1081225A1 (ru) |
IL (1) | IL156234A0 (ru) |
NZ (1) | NZ526243A (ru) |
RU (1) | RU2322497C2 (ru) |
WO (1) | WO2002102997A2 (ru) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8273570B2 (en) * | 2000-05-16 | 2012-09-25 | Riken | Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells |
WO2002057429A2 (en) * | 2001-01-02 | 2002-07-25 | Stemron, Inc. | A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
US7588937B2 (en) | 2001-10-03 | 2009-09-15 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US8153424B2 (en) * | 2001-10-03 | 2012-04-10 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
AU2002363659B2 (en) * | 2001-11-15 | 2008-09-25 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
CN1638640A (zh) | 2002-02-12 | 2005-07-13 | 雷文生物技术公司 | 人胎儿膀胱来源的上皮细胞 |
US20040091936A1 (en) | 2002-05-24 | 2004-05-13 | Michael West | Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
AU2003237257A1 (en) | 2002-05-24 | 2003-12-12 | Advanced Cell Technology, Inc. | A bank of stem cells for transplantation |
ES2571355T3 (es) | 2002-12-16 | 2016-05-24 | Technion Res & Dev Foundation | Sistema de cultivo sin células alimentadoras ni xenocontaminantes para células madre embrionarias humanas |
AU2004252566B2 (en) | 2003-06-27 | 2011-09-15 | Ethicon, Incorporated | Postpartum cells derived from placental tissue, and methods of making and using the same |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US8491883B2 (en) | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
GB2421029B (en) * | 2003-08-29 | 2008-04-09 | Wisconsin Alumni Res Found | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
CA2548910C (en) * | 2003-12-11 | 2010-11-02 | Japan Science And Technology Agency | Method for three-dimensional cartilage tissue engineering using bone marrow cells in simulated microgravity environment |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
MXPA06007252A (es) | 2003-12-23 | 2007-01-23 | Cythera Inc | Endodermo definitivo. |
US7622108B2 (en) | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
WO2005108559A2 (en) | 2004-04-23 | 2005-11-17 | Bioe, Inc. | Multi-lineage progenitor cells |
ES2801001T3 (es) * | 2004-04-27 | 2021-01-07 | Viacyte Inc | Endodermo que expresa pdx1 |
KR100644296B1 (ko) * | 2004-07-24 | 2006-11-10 | 정필훈 | 생체 공학적 턱뼈 및 치아 재건 방법 |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
EP1831356B1 (en) | 2004-12-23 | 2017-01-25 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
CA2589063C (en) | 2004-12-23 | 2016-08-09 | Ethicon Incorporated | Treatment of parkinson's disease and related disorders using postpartum derived cells |
EP3354723B1 (en) | 2005-08-29 | 2023-12-13 | Technion Research & Development Foundation Ltd. | Media for culturing stem cells |
US20070128727A1 (en) * | 2005-11-08 | 2007-06-07 | Kraemer Fredric B | Methods for differentiation of embryonic stem cells |
WO2007070870A1 (en) | 2005-12-16 | 2007-06-21 | Ethicon, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
JP5179376B2 (ja) | 2005-12-19 | 2013-04-10 | エシコン・インコーポレイテッド | ローラーボトルでの分娩後取り出し細胞の体外増殖 |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
CN101374942A (zh) * | 2006-01-31 | 2009-02-25 | 阿斯比奥制药株式会社 | 干细胞及胚胎来源的心肌细胞及推定的心肌细胞的纯化方法 |
EP2019858B1 (en) | 2006-04-17 | 2012-06-13 | BioE LLC | Differentiation of multi-lineage progenitor cells to respiratory epithelial cells |
RU2433174C2 (ru) | 2006-04-28 | 2011-11-10 | Дайити Санкио Компани, Лимитед | Способ индукции дифференциации плюрипотентных стволовых клеток в кардиомиоциты |
PT2733203T (pt) | 2006-08-02 | 2019-01-23 | Technion Res & Dev Foundation | Métodos de expansão de células estminais embrionárias numa cultura de suspensão |
US20080108044A1 (en) * | 2006-11-08 | 2008-05-08 | Deepika Rajesh | In vitro differentiation of hematopoietic cells from primate embryonic stem cells |
AU2008308531B2 (en) | 2007-10-05 | 2014-04-24 | Ethicon, Incorporated | Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
GB0800524D0 (en) * | 2008-01-14 | 2008-02-20 | Univ Brighton | Cell culture system |
US10557116B2 (en) | 2008-12-19 | 2020-02-11 | DePuy Synthes Products, Inc. | Treatment of lung and pulmonary diseases and disorders |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
CA2756600C (en) | 2009-03-26 | 2019-08-20 | Advanced Technologies And Regenerative Medicine, Llc | Human umbilical cord tissue cells as therapy for alzheimer's disease |
US20100247495A1 (en) * | 2009-03-30 | 2010-09-30 | Tom Ichim | Treatment of Muscular Dystrophy |
DK2499236T3 (da) | 2009-11-12 | 2020-03-23 | Technion Res & Dev Foundation | Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand |
JP2013531987A (ja) * | 2010-06-14 | 2013-08-15 | キアゲン ゲーエムベーハー | 固定生物学的試料から生体分子を抽出するためのターゲット細胞または組織を決定するための方法 |
KR101981450B1 (ko) | 2011-12-23 | 2019-08-28 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | 인간 제대 조직-유래된 세포의 검출 |
JP6562897B2 (ja) * | 2013-03-13 | 2019-08-21 | ユニバーシティー オブ マイアミUniversity Of Miami | 細胞培養上清および生体液からの微小胞の単離および精製のための方法 |
WO2016170938A1 (ja) * | 2015-04-20 | 2016-10-27 | 国立大学法人岡山大学 | がんの非ヒトモデル動物及びその作製方法、がん幹細胞及びその製造方法 |
CN107338214B (zh) * | 2016-04-29 | 2020-04-17 | 湖南光琇高新生命科技有限公司 | 成纤维细胞及其制备方法和应用、细胞分泌液及其应用 |
JP6276487B1 (ja) * | 2016-07-19 | 2018-02-07 | 株式会社マンダム | 汗腺の動態の観察方法 |
KR102169122B1 (ko) * | 2016-12-29 | 2020-10-23 | 의료법인 성광의료재단 | 중간엽 줄기세포의 제조방법 |
KR20210032449A (ko) * | 2018-07-17 | 2021-03-24 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 면역조작된 만능성 줄기세포로부터 유래된 키메라 항원 수용체 t 세포 |
CN109298174A (zh) * | 2018-09-26 | 2019-02-01 | 姜云瀚 | 一种多色免疫荧光标记方法和成像方法 |
CN113215081B (zh) * | 2021-06-01 | 2023-04-14 | 华中科技大学同济医学院附属同济医院 | 诱导干细胞分化为甲状旁腺细胞的方法及其组合物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
AU3814393A (en) * | 1992-03-23 | 1993-10-21 | University Of North Carolina At Chapel Hill, The | Small animal model for studying cholesterol metabolism |
GB9308271D0 (en) * | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517779D0 (en) * | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5905042A (en) * | 1996-04-01 | 1999-05-18 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Cultured inner cell mass cell lines derived from bovine or porcine embryos |
US5945577A (en) * | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
NZ502129A (en) * | 1997-07-03 | 2005-02-25 | Univ Massachusetts | Cloning using donor nuclei from non-serum starved, differentiated cells |
GB9809178D0 (en) * | 1998-04-29 | 1998-07-01 | Univ Edinburgh | Nuclear reprogramming of somatic cells |
AU5575899A (en) * | 1998-08-20 | 2000-03-14 | Biotransplant Incorporated | Inbred mhc-homozygous miniature swine and uses thereof |
ATE514772T1 (de) * | 1999-08-05 | 2011-07-15 | Abt Holding Co | Multipotente erwachsene stammzellen und verfahren zu deren isolierung |
JP2003514516A (ja) * | 1999-10-28 | 2003-04-22 | ユニバーシティ オブ マサチューセッツ | 多能性細胞と細胞株の雌性発生的または雄性発生的産生および分化した細胞と組織を産生するためのその使用 |
CA2388510A1 (en) * | 1999-11-02 | 2001-05-10 | James M. Robl | Use of haploid genomes for genetic diagnosis, modification and multiplication |
WO2001059076A2 (en) * | 2000-02-09 | 2001-08-16 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses |
GB0025088D0 (en) * | 2000-10-13 | 2000-11-29 | Univ Edinburgh | Stem cells |
GB0026252D0 (en) * | 2000-10-26 | 2000-12-13 | Univ Edinburgh | Pluripotential stem cells |
US20030027331A1 (en) * | 2000-11-30 | 2003-02-06 | Yan Wen Liang | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same |
WO2002057429A2 (en) * | 2001-01-02 | 2002-07-25 | Stemron, Inc. | A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
-
2001
- 2001-11-30 KR KR10-2003-7007343A patent/KR20030088022A/ko not_active Application Discontinuation
- 2001-11-30 EP EP01274145A patent/EP1395652A2/en not_active Withdrawn
- 2001-11-30 CA CA002430627A patent/CA2430627A1/en not_active Abandoned
- 2001-11-30 JP JP2003506451A patent/JP2004532648A/ja active Pending
- 2001-11-30 AU AU2001297880A patent/AU2001297880B2/en not_active Ceased
- 2001-11-30 RU RU2003119168/13A patent/RU2322497C2/ru not_active IP Right Cessation
- 2001-11-30 NZ NZ526243A patent/NZ526243A/en unknown
- 2001-11-30 KR KR1020087012507A patent/KR20080051191A/ko not_active Application Discontinuation
- 2001-11-30 WO PCT/US2001/044627 patent/WO2002102997A2/en active IP Right Grant
- 2001-11-30 US US09/997,240 patent/US20020168763A1/en not_active Abandoned
- 2001-11-30 IL IL15623401A patent/IL156234A0/xx unknown
- 2001-11-30 CN CNB018223958A patent/CN100422315C/zh not_active Expired - Fee Related
-
2006
- 2006-01-23 HK HK06100997.7A patent/HK1081225A1/xx not_active IP Right Cessation
-
2008
- 2008-10-01 JP JP2008256603A patent/JP2009028049A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN100422315C (zh) | 2008-10-01 |
CA2430627A1 (en) | 2002-12-27 |
JP2009028049A (ja) | 2009-02-12 |
RU2003119168A (ru) | 2005-02-20 |
NZ526243A (en) | 2006-02-24 |
US20020168763A1 (en) | 2002-11-14 |
KR20080051191A (ko) | 2008-06-10 |
WO2002102997A2 (en) | 2002-12-27 |
WO2002102997A3 (en) | 2003-12-24 |
IL156234A0 (en) | 2004-01-04 |
JP2004532648A (ja) | 2004-10-28 |
CN1643135A (zh) | 2005-07-20 |
RU2322497C2 (ru) | 2008-04-20 |
AU2001297880B8 (en) | 2003-01-02 |
AU2001297880B2 (en) | 2007-05-31 |
EP1395652A2 (en) | 2004-03-10 |
KR20030088022A (ko) | 2003-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1081225A1 (en) | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same | |
HK1252977A1 (zh) | 收集胎盤幹細胞的方法 | |
IL204766A (en) | Embryonic stem cells and nerve cells derived from them | |
AU2002301347A1 (en) | Embryonic stem cells and neural progenitor cells derived therefrom | |
IL142748A0 (en) | Embryonic stem cells | |
IL153095A0 (en) | Embryonic stem cells, methods for culturing the same and methods utilizing the same | |
IL152785A0 (en) | Compositions and methods for cell dedifferentiation and tissue regeneration | |
IL145002A0 (en) | Adipose-derived stem cells and lattices | |
MXPA02003733A (es) | Metodos para producir celulas progenitoras diferenciadas y celulas troncales embrionicas de lineas de descendencia defectivas. | |
EP1333086A4 (en) | CELL CULTURE CONTAINER | |
AU2002230669A1 (en) | Postmortem stem cells | |
AU2003224702A8 (en) | Stem cell selection and differentiation | |
EP1312668A4 (en) | CULTURE MEDIUM FOR STEM CELLS, CULTIVATION METHOD AND METHOD FOR USE THEREOF | |
AU6438901A (en) | Protein translocation into plant cells | |
IL139322A0 (en) | Process for obtaining stem cells | |
AU2002211183A1 (en) | Prosthetic construct and methods for its manufacture and use | |
AU1154802A (en) | Single cell electroporation | |
AU2001247880A1 (en) | Methods to prepare and use epidermal stem cells | |
GB2399819B (en) | Method and lentiviral vector for transducing human embryonic stem cells | |
GB2351296B (en) | Keratinocyte stem cells | |
AU4520101A (en) | Lung stem cells and lung regeneration | |
AU3860101A (en) | Utility lighter | |
GB0025088D0 (en) | Stem cells | |
GB0229261D0 (en) | Cells,culture methods and their uses | |
EP1443106A4 (en) | EMBRYONIC STEM CELLS DERIVED FROM SOMATIC CELLS, AND DIFFERENTIATED CELLS THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121130 |